Patent issue settled and new 5 year agreement with BSP
BLIS Technologies Limited: Ground Floor, 399 Moray Place, Dunedin Central 9016, PO Box 2208, Dunedin 9044, New Zealand
T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz
2 July 2025
Patent issue settled and new 5 year agreement with BSP
On 14 October 2024, based on the information we had on hand at the time, we advised the market
about a breach of contract by Bluestone Pharma GmbH (BSP) and Lactosan GmbH & Co. KG
(Lactosan).
Since then, BSP and BLIS Technologies Limited (BLIS) have been progressing communications in
relation to the patent applications filed by BSP. BLIS and BSP are pleased to report that these
negotiations have concluded, with BSP and BLIS agreeing that the patent applications will be jointly
owned. This is a positive step forward for both BLIS, BSP and Lactosan, and provides certainty of
access for BLIS and its licensees to this market leading technology developed, and contributed to, by
BLIS, BSP and Lactosan. As part of this arrangement, BLIS, BSP and Lactosan have released each
other of all claims and causes of action arising from the publication of the patent applications.
BLIS would like to thank both BSP and Lactosan for their willingness to engage positively on this
matter and the transparent and ethical manner in which both parties have conducted themselves
during the course of the negotiations.
BLIS and BSP are also pleased to announce they have renegotiated a five year extension to their
existing supply agreement that was scheduled to expire this month.
Ends
For further information, please contact:
Scott Johnson
CEO
+64 21 488 831
About BLIS Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut.
Combining innovation with evidence-based research and the highest quality production controls enables
the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath),
immune support, teeth and gum health and skin health. BLIS
®
products are sold throughout New Zealand
and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at
www.blis.co.nz.
Website: www.blis.co.nz
Instagram: @blisprobiotics #blisk12 #blism18 #blisq24
Facebook: @BLISProbiotics
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- THL — Tourism Holdings Limited: thl receives unsolicited non-binding offer2025-06-15
“offer, or any on/off market sale, and that sale price is greater than the price at which the relevant shares were sold to BGH. Additionally, shares purchased from ANZ also include a matching top-up payment if BGH acquires shares on market within 20 business days after t…”
- THL — Tourism Holdings Limited: thl outlines its growth roadmap2025-08-03
“Tourism Holdings Limited 470 Oruarangi Road, Māngere, Auckland 2022 PO Box 4293, Shortland Street, Auckland 1140, New Zealand www.thlonline.com 4 August 2025 NZX | ASX | MEDIA RELEASE TOURISM HOLDINGS LIMITED (thl) THL OUTLINES ITS GROWTH ROADMAP Tourism Ho…”
- THL — Tourism Holdings Limited: thl responds to NBIO, confirms uNPAT expectations2025-08-03
“Tourism Holdings Limited 470 Oruarangi Road, Māngere, Auckland 2022 PO Box 4293, Shortland Street, Auckland 1140, New Zealand www.thlonline.com 4 August 2025 NZX | ASX | MEDIA RELEASE TOURISM HOLDINGS LIMITED (thl) THL RESPONDS TO NBIO, CONFIRMS FY25 uNPAT EXPE…”